1,3-dipropyl-8-cyclopentylxanthine has been researched along with bucladesine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Frauman, AG; Moses, AC | 1 |
| Gean, PW; Huang, CC | 1 |
| el-Ani, D; Jacobson, KA; Shainberg, A | 1 |
| Bauer, J; Fiebich, BL; Heese, K; Otten, U | 1 |
| Brunsden, AM; Grundy, D | 1 |
| Emala, CW; Lee, HT | 1 |
| Greenberg, AG; Kraemer, FB; Xue, B; Zemel, MB | 1 |
| Bialik, I; Szkudelska, K; Szkudelski, T | 1 |
| Gu, R; Li, W; Shan, H; Wang, J; Wang, WH; Xu, Y; Yang, B; Zhang, Y | 1 |
| Nogowski, L; Szkudelska, K; Szkudelski, T | 1 |
11 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and bucladesine
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
The A1 adenosine receptor antagonist 1,3, dipropyl-8-cyclopentylxanthine (DPCPX) displays adenosine agonist properties in the FRTL5 thyroid cell line.
Topics: Adenosine; Animals; Binding, Competitive; Bucladesine; Cell Line; Cyclic AMP; DNA; Rats; Receptors, Purinergic; Thyroid Gland; Thyrotropin; Xanthines | 1989 |
Cyclic adenosine-3',5'-monophosphate potentiates the synaptic potential mediated by NMDA receptors in the amygdala.
Topics: Amygdala; Animals; Bucladesine; Colforsin; Cyclic AMP; Electric Stimulation; Long-Term Potentiation; Male; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission; Xanthines | 1995 |
Effects of theophylline and dibutyryl-cAMP on adenosine receptors and heart rate in cultured cardiocytes.
Topics: Animals; Bucladesine; Cells, Cultured; Creatine Kinase; Dose-Response Relationship, Drug; Heart Rate; Kinetics; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Antagonists; Radioligand Assay; Rats; Receptors, Purinergic P1; Reproducibility of Results; Theophylline; Xanthines | 1996 |
Nerve growth factor (NGF) expression in rat microglia is induced by adenosine A2a-receptors.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Animals, Newborn; Antihypertensive Agents; Bucladesine; Colforsin; Gene Expression; Microglia; Nerve Growth Factors; Phenethylamines; Polymerase Chain Reaction; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptors, Purinergic P1; Vasodilator Agents; Xanthines | 1997 |
Sensitization of visceral afferents to bradykinin in rat jejunum in vitro.
Topics: Adenosine; Animals; Bradykinin; Bucladesine; Cyclooxygenase Inhibitors; Dinoprostone; Histamine; Histamine Antagonists; Histamine H2 Antagonists; In Vitro Techniques; Jejunum; Male; Membrane Potentials; Naproxen; Neurons, Afferent; Piperidines; Ranitidine; Rats; Rats, Inbred Strains; Serotonin; Stimulation, Chemical; Triazines; Triazoles; Xanthines | 1999 |
Systemic adenosine given after ischemia protects renal function via A(2a) adenosine receptor activation.
Topics: Adenosine; Analysis of Variance; Animals; Bucladesine; Caffeine; Kidney; Male; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Reperfusion Injury; Vasodilation; Xanthines | 2001 |
Mechanism of intracellular calcium ([Ca2+]i) inhibition of lipolysis in human adipocytes.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; 8-Bromo Cyclic Adenosine Monophosphate; Adipocytes; Androstadienes; Bucladesine; Calcium; Colforsin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Dose-Response Relationship, Drug; Humans; Insulin; Isoproterenol; Lipolysis; Phosphodiesterase Inhibitors; Phosphorylation; Potassium Chloride; Quinolones; Sterol Esterase; Wortmannin; Xanthines | 2001 |
Adipocyte lipolysis, hormonal and metabolic changes in ethanol-drinking rats.
Topics: Adenosine A1 Receptor Antagonists; Adipocytes; Adipose Tissue; Alcohol Drinking; Animals; Bucladesine; Epinephrine; Ethanol; Insulin; Leptin; Lipolysis; Liver; Male; Random Allocation; Rats; Rats, Wistar; Weight Gain; Xanthines | 2004 |
Adenosine stimulates the basolateral 50 pS K channels in the thick ascending limb of the rat kidney.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Adenylyl Cyclases; Algorithms; Animals; Bucladesine; Caffeine; Dose-Response Relationship, Drug; Enzyme Activation; Female; Kidney; Male; Patch-Clamp Techniques; Phenethylamines; Potassium Channels; Rats; Rats, Sprague-Dawley; Receptors, Adenosine A2; Stimulation, Chemical; Xanthines | 2007 |
Short-term regulation of adiponectin secretion in rat adipocytes.
Topics: Adenosine A1 Receptor Antagonists; Adipocytes; Adiponectin; Animals; Bucladesine; Epinephrine; In Vitro Techniques; Insulin; Male; Palmitates; Rats; Rats, Wistar; Xanthines | 2011 |